A – 122 The Impact of Mood in HD in Siblings with Genetically Confirmed Huntington’s Disease

Abstract Objective Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. We present two siblings with genetically confirmed HD who reported cognitive concerns. Method Two siblings, Patient A (PtA, 51-year-old female) and Patient B (PtB, 45-year-old male), reported onset of cognitive symptoms 3 (PtA) and 5 (PtB) years prior to evaluation. Presenting symptoms included word-finding difficulties, inattention, decline in reading retention and comprehension, slowed thinking, forgetfulness, and spatial disorientation. PtB additionally noted multitasking difficulties and misplacing objects. Genetic testing revealed identical CAG repeats lengths (41/16 for both). Results PtA exhibited low average performance on phonemic fluency (FAS T=39) and figure copy (Benson Figure Copy T=36) and reported significant emotional distress (BDI-II=42, BAI=46). PtB demonstrated exceptionally low nonverbal encoding (BVMT-R-Total Recall T=23), while below average for reproduction of a complex design He was diagnosed with persistent depressive disorder (BDI-II=34, BAI=21), which emerged post-HD diagnosis, and reported distress related to caregiving for a family member with HD. Despite both patients endorsing elevated scores on BDI-II and BAI, their symptomatology differed. Conclusion Despite identical CAG repeats and environmental backgrounds, PtA and PtB presented with markedly different cognitive and emotional profiles. These phenotypic differences highlight the variability in clinical manifestation even among siblings raised together. This underscores the importance of utilizing a comprehensive neuropsychological battery evaluating cognitive and emotional presentations is essential to capture the nuanced phenotypic variability in HD, allowing for more personalized and timely interventions.

Authors

Publication Details

Journal
Archives of Clinical Neuropsychology
Published
2025-09-26
DOI
https://doi.org/10.1093/arclin/acaf084.144
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A – 122 The Impact of Mood in HD in Siblings with Genetically Confirmed Huntington’s Disease

Daniella Lopez Palacios, Sonya Kaur, Marina Sarno, Bonnie Levin et al.
Archives of Clinical Neuropsychology
Genetic Neurodegenerative Diseases
article

A – 122 The Impact of Mood in HD in Siblings with Genetically Confirmed Huntington’s Disease

Daniella Lopez Palacios, Sonya Kaur, Marina Sarno, Bonnie Levin, Katalina McInerney, Sofia Coll, Carolina Wiebalk, Enoch Oduro
article en

Abstract

Abstract Objective Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. We present two siblings with genetically confirmed HD who reported cognitive concerns. Method Two siblings, Patient A (PtA, 51-year-old female) and Patient B (PtB, 45-year-old male), reported onset of cognitive symptoms 3 (PtA) and 5 (PtB) years prior to evaluation. Presenting symptoms included word-finding difficulties, inattention, decline in reading retention and comprehension, slowed thinking, forgetfulness, and spatial disorientation. PtB additionally noted multitasking difficulties and misplacing objects. Genetic testing revealed identical CAG repeats lengths (41/16 for both). Results PtA exhibited low average performance on phonemic fluency (FAS T=39) and figure copy (Benson Figure Copy T=36) and reported significant emotional distress (BDI-II=42, BAI=46). PtB demonstrated exceptionally low nonverbal encoding (BVMT-R-Total Recall T=23), while below average for reproduction of a complex design He was diagnosed with persistent depressive disorder (BDI-II=34, BAI=21), which emerged post-HD diagnosis, and reported distress related to caregiving for a family member with HD. Despite both patients endorsing elevated scores on BDI-II and BAI, their symptomatology differed. Conclusion Despite identical CAG repeats and environmental backgrounds, PtA and PtB presented with markedly different cognitive and emotional profiles. These phenotypic differences highlight the variability in clinical manifestation even among siblings raised together. This underscores the importance of utilizing a comprehensive neuropsychological battery evaluating cognitive and emotional presentations is essential to capture the nuanced phenotypic variability in HD, allowing for more personalized and timely interventions.

Archives of Clinical NeuropsychologyVol. 40(Supplement_2)
Openalex Percentile: Top 71%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.